Cargando…
Association between EZH2 expression, silencing of tumor suppressors and disease outcome in solid tumors
EZH2, the main catalytic component of the Polycomb Repressive Complex 2 (PRC2) is apparently upregulated in most solid tumors. Furthermore its expression generally associates with poor prognosis. It was proposed that this correlation reflects a causal event, EZH2 mediating the silencing of key tumor...
Autores principales: | Wassef, M., Michaud, A., Margueron, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004685/ https://www.ncbi.nlm.nih.gov/pubmed/27419533 http://dx.doi.org/10.1080/15384101.2016.1208872 |
Ejemplares similares
-
Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73
por: Dulloo, Iqbal, et al.
Publicado: (2015) -
Glucose—a sweet way to die: Metabolic switching modulates tumor cell death
por: MacFarlane, Marion, et al.
Publicado: (2012) -
Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabolome to signaling network activities
por: Marchan, Rosemarie, et al.
Publicado: (2012) -
Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation
por: Lochhead, Pamela A., et al.
Publicado: (2016) -
Multifunctional roles of the autoimmune disease-associated tyrosine phosphatase PTPN22 in regulating T cell homeostasis
por: Salmond, Robert J, et al.
Publicado: (2015)